AngioDynamics PE Ratio 2010-2024 | ANGO
Current and historical p/e ratio for AngioDynamics (ANGO) from 2010 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. AngioDynamics PE ratio as of January 20, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| AngioDynamics PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-01-17 | 12.43 | 0.00 | |
| 2024-11-30 | 6.93 | $-5.63 | 0.00 |
| 2024-08-31 | 7.46 | $-6.09 | 0.00 |
| 2024-05-31 | 6.31 | $-4.63 | 0.00 |
| 2024-02-29 | 5.49 | $-4.84 | 0.00 |
| 2023-11-30 | 6.53 | $-0.35 | 0.00 |
| 2023-08-31 | 8.03 | $0.16 | 50.19 |
| 2023-05-31 | 9.46 | $-1.32 | 0.00 |
| 2023-02-28 | 12.38 | $-0.94 | 0.00 |
| 2022-11-30 | 12.95 | $-0.83 | 0.00 |
| 2022-08-31 | 22.14 | $-0.83 | 0.00 |
| 2022-05-31 | 19.63 | $-0.68 | 0.00 |
| 2022-02-28 | 23.53 | $-1.03 | 0.00 |
| 2021-11-30 | 25.75 | $-0.99 | 0.00 |
| 2021-08-31 | 28.30 | $-0.89 | 0.00 |
| 2021-05-31 | 23.12 | $-0.82 | 0.00 |
| 2021-02-28 | 20.95 | $-4.41 | 0.00 |
| 2020-11-30 | 14.22 | $-4.47 | 0.00 |
| 2020-08-31 | 9.37 | $-4.43 | 0.00 |
| 2020-05-31 | 10.21 | $-4.35 | 0.00 |
| 2020-02-29 | 11.49 | $1.29 | 8.91 |
| 2019-11-30 | 15.37 | $1.46 | 10.53 |
| 2019-08-31 | 18.37 | $1.59 | 11.55 |
| 2019-05-31 | 18.79 | $1.61 | 11.67 |
| 2019-02-28 | 22.41 | $0.13 | 172.38 |
| 2018-11-30 | 21.49 | $0.48 | 44.77 |
| 2018-08-31 | 22.42 | $0.43 | 52.14 |
| 2018-05-31 | 21.03 | $0.44 | 47.80 |
| 2018-02-28 | 16.29 | $0.08 | 203.63 |
| 2017-11-30 | 17.18 | $-0.21 | 0.00 |
| 2017-08-31 | 17.03 | $0.15 | 113.53 |
| 2017-05-31 | 15.08 | $0.19 | 79.37 |
| 2017-02-28 | 16.35 | $-0.72 | 0.00 |
| 2016-11-30 | 16.30 | $-0.78 | 0.00 |
| 2016-08-31 | 16.54 | $-1.16 | 0.00 |
| 2016-05-31 | 12.01 | $-1.22 | 0.00 |
| 2016-02-29 | 10.87 | $-0.03 | 0.00 |
| 2015-11-30 | 11.90 | $-0.17 | 0.00 |
| 2015-08-31 | 14.76 | $-0.12 | 0.00 |
| 2015-05-31 | 16.05 | $-0.08 | 0.00 |
| 2015-02-28 | 18.60 | $-0.09 | 0.00 |
| 2014-11-30 | 17.50 | $0.17 | 102.94 |
| 2014-08-31 | 14.11 | $0.13 | 108.54 |
| 2014-05-31 | 14.33 | $0.10 | 143.30 |
| 2014-02-28 | 15.40 | $0.11 | 140.00 |
| 2013-11-30 | 15.45 | $-0.06 | 0.00 |
| 2013-08-31 | 10.90 | $-0.00 | 0.00 |
| 2013-05-31 | 10.88 | $-0.01 | 0.00 |
| 2013-02-28 | 12.39 | $-0.26 | 0.00 |
| 2012-11-30 | 10.54 | $-0.30 | 0.00 |
| 2012-08-31 | 11.44 | $-0.27 | 0.00 |
| 2012-05-31 | 12.04 | $-0.20 | 0.00 |
| 2012-02-29 | 13.02 | $0.04 | 325.50 |
| 2011-11-30 | 15.12 | $0.26 | 58.15 |
| 2011-08-31 | 14.40 | $0.30 | 48.00 |
| 2011-05-31 | 15.70 | $0.33 | 47.58 |
| 2011-02-28 | 16.82 | $0.51 | 32.98 |
| 2010-11-30 | 13.97 | $0.49 | 28.51 |
| 2010-08-31 | 15.22 | $0.49 | 31.06 |
| 2010-05-31 | 14.77 | $0.50 | 29.54 |
| 2010-02-28 | 16.26 | $0.47 | 34.60 |
| 2009-11-30 | 15.55 | $0.42 | 37.02 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.503B | $0.304B |
| AngioDynamics Inc. designs, manufactures and sells a wide range of medical, surgical and diagnostic devices. The devices are generally used in minimally invasive, image-guided procedures. AngioDynamics product offerings fall within three Global Business Units, namely Oncology/Surgery, Endovascular Therapies and Vascular Access. Endovascular Therapies product offerings support the medical areas of Thrombus Management, Atherectomy, Peripheral Products and Venous Insufficiency. The Thrombus Management portfolio includes the proprietary AngioVac venous drainage cannula and circuit as well as catheter directed thrombolytic devices. Vascular Access arm offers advanced imaging equipment to guide the placement of catheters that primarily deliver short-term drug therapies. IGVA procedures include the placement of Peripherally Inserted Central Catheters lines, implantable ports and central venous catheters. Oncology/Surgery division includes Microwave Ablation, Radiofrequency Ablation and NanoKnife product lines. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $214.066B | 26.11 |
| Intuitive Surgical (ISRG) | United States | $211.086B | 110.36 |
| Alcon (ALC) | Switzerland | $41.615B | 27.84 |
| Edwards Lifesciences (EW) | United States | $41.156B | 26.14 |
| IQVIA Holdings (IQV) | United States | $35.821B | 19.74 |
| IDEXX Laboratories (IDXX) | United States | $34.331B | 40.43 |
| DexCom (DXCM) | United States | $32.958B | 49.63 |
| Waters (WAT) | United States | $23.988B | 35.47 |
| STERIS (STE) | Ireland | $20.691B | 23.82 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.710B | 0.00 |
| Hologic (HOLX) | United States | $15.740B | 17.09 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.538B | 13.90 |
| Globus Medical (GMED) | United States | $12.364B | 31.31 |
| Sysmex ADR (SSMXY) | Japan | $11.726B | 0.00 |
| Penumbra (PEN) | United States | $10.120B | 99.13 |
| Masimo (MASI) | United States | $9.225B | 44.63 |
| Glaukos (GKOS) | United States | $8.623B | 0.00 |
| Teleflex (TFX) | United States | $8.419B | 13.43 |
| Integer Holdings (ITGR) | United States | $4.729B | 26.81 |
| Inari Medical (NARI) | United States | $4.657B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $3.967B | 0.00 |
| Veracyte (VCYT) | United States | $3.145B | 94.37 |
| Nihon Kohden (NHNKY) | Japan | $2.658B | 20.19 |
| LivaNova (LIVN) | United Kingdom | $2.623B | 15.14 |
| Tandem Diabetes Care (TNDM) | United States | $2.309B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.167B | 19.48 |
| TransMedics (TMDX) | United States | $1.920B | 60.85 |
| Integra LifeSciences Holdings (IART) | United States | $1.860B | 9.72 |
| Alphatec Holdings (ATEC) | United States | $1.641B | 0.00 |
| Artivion (AORT) | United States | $1.288B | 85.33 |
| RxSight (RXST) | United States | $1.225B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.083B | 0.00 |
| OPKO Health (OPK) | United States | $1.003B | 0.00 |
| Paragon 28 (FNA) | United States | $0.911B | 0.00 |
| AxoGen (AXGN) | United States | $0.796B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.758B | 17.88 |
| IRadimed (IRMD) | United States | $0.750B | 40.53 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.732B | 12.44 |
| SiBone (SIBN) | United States | $0.700B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.693B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.658B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.599B | 31.55 |
| Treace Medical Concepts (TMCI) | United States | $0.543B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.458B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.449B | 0.00 |
| CVRx (CVRX) | United States | $0.428B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.418B | 22.60 |
| ClearPoint Neuro (CLPT) | United States | $0.415B | 0.00 |
| NeuroPace (NPCE) | United States | $0.357B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.273B | 0.00 |
| Inogen (INGN) | United States | $0.249B | 0.00 |
| Accuray (ARAY) | United States | $0.225B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.215B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.187B | 0.00 |
| Nevro (NVRO) | United States | $0.171B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.144B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.108B | 11.51 |
| Atossa Genetics (ATOS) | United States | $0.104B | 0.00 |
| 908 Devices (MASS) | United States | $0.104B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.098B | 0.00 |
| LENSAR (LNSR) | United States | $0.097B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.094B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.088B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.081B | 0.00 |
| Neuronetics (STIM) | United States | $0.075B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.073B | 0.00 |
| Hyperfine (HYPR) | United States | $0.071B | 0.00 |
| InspireMD (NSPR) | Israel | $0.071B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.059B | 30.93 |
| Baird Medical Investment Holdings (BDMD) | $0.058B | 0.00 | |
| EnVVeno Medical (NVNO) | United States | $0.058B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.053B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.050B | 0.00 |
| Spectral AI (MDAI) | United States | $0.036B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.033B | 0.00 |
| Precision Optics (POCI) | United States | $0.031B | 0.00 |
| Envoy Medical (COCH) | United States | $0.029B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.027B | 0.00 |
| NexGel (NXGL) | United States | $0.024B | 0.00 |
| DarioHealth (DRIO) | United States | $0.024B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.020B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.014B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.013B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.013B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.012B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.008B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.008B | 0.00 |
| PAVmed (PAVM) | United States | $0.007B | 0.00 |
| Tenon Medical (TNON) | United States | $0.006B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |